Sight Sciences, Inc. (SGHT)

↓ Download CSV

CIK 0001531177 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Sight Sciences, Inc. reported revenue of $77.36M, down 3.1% from the prior year. The company ran a net loss, with a net margin of -49.7% and a gross margin of 86.2%. It held $115.30M in total assets against $51.36M in total liabilities.

Key ratios (FY2025)

86.2%
Gross margin
-48.0%
Operating margin
-49.7%
Net margin
-60.1%
Return on equity
-3.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019
Revenue$77.36M$79.87M$81.06M$71.33M$48.96M$27.64M
Cost of Revenue$10.70M$11.58M$11.88M$12.36M$8.61M$9.21M
Gross Profit$66.67M$68.28M$69.17M$58.97M$40.35M$18.43M
Operating Income-$37.10M-$50.53M-$57.27M-$83.95M-$51.48M-$32.19M
Net Income-$38.43M-$51.51M-$55.55M-$86.24M-$62.96M-$34.69M
EPS (Diluted)$-0.74$-1.03$-1.14$-1.80$-2.36
Total Assets$115.30M$142.84M$166.65M$213.07M$280.19M$72.81M
Total Liabilities$51.36M$55.32M$46.44M$53.00M$48.08M$44.32M
Shareholders' Equity$63.94M$87.52M$120.22M$160.08M$232.11M-$88.85M-$54.68M
Cash & Equivalents$91.97M$120.36M$138.13M$185.00M$260.69M$61.51M
Operating Cash Flow-$29.69M-$22.35M-$47.18M-$75.97M-$52.54M-$32.17M
Capital Expenditures$224.0K$385.0K$791.0K$970.0K$813.0K$953.0K
Shares Outstanding53.49M50.94M49.13M48.30M47.50M9.51M